Ventyx Biosciences Inc (VTYX)

Apr 29, 2025

Geode Capital Management LLC Increases Stock Position in Ventyx Biosciences, Inc. (NASDAQ:VTYX) - Defense World

Apr 29, 2025

Apr 29, 2025

Renaissance Technologies LLC Acquires 310,800 Shares of Ventyx Biosciences, Inc. (NASDAQ:VTYX) - Defense World

Apr 29, 2025

Apr 28, 2025

Stock Market Recap: Ventyx Biosciences Inc (VTYX) Concludes at 1.15, a -4.96 Surge/Decline - DWinneX

Apr 28, 2025

Apr 28, 2025

Ventyx Biosciences Inc’s Market Journey: Closing Strong at 1.43, Up 0.70 - DWinneX

Apr 28, 2025

Apr 27, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 27, 2025

Apr 25, 2025

The Psychology of Ventyx Biosciences Inc Inc. (VTYX) Price Performance: Understanding Market Sentiment - investchronicle.com

Apr 25, 2025

Apr 25, 2025

JPMorgan Chase & Co. Trims Stake in Ventyx Biosciences, Inc. (NASDAQ:VTYX) - Defense World

Apr 25, 2025

Apr 24, 2025

VTYX FINAL DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Ventyx Biosciences, Inc. Investors to Secure Counsel Before Important April 30 Deadline in Securities Class ActionVTYX - The Globe and Mail

Apr 24, 2025

Apr 24, 2025

Trading Day Review: Ventyx Biosciences Inc (VTYX) Loses Momentum, Closing at 1.16 - DWinneX

Apr 24, 2025

Apr 24, 2025

Ventyx Biosciences Inc [NASDAQ: VTYX] Sees Decrease in Stock Value - knoxdaily.com

Apr 24, 2025

Apr 23, 2025

Ventyx Biosciences Inc (VTYX) stock analysis: A comprehensive overview - uspostnews.com

Apr 23, 2025

Apr 14, 2025

Arthralgia Market to Reach New Heights in Growth by 2032, DelveInsight Predicts | Sun Pharma, Bristol-Myers Squibb, UCB Biopharma, Affibody, Ventyx Biosciences, Aclaris Therapeutics, AbbVie, Novartis - The Globe and Mail

Apr 14, 2025

Apr 11, 2025

VENTYX INVESTOR UPDATE: Ventyx’s (Nasdaq:VTYX) Board is Being Investigated for Insider Trading, Long-term Investors Are Urged to Contact the Firm for Details - ACCESS Newswire

Apr 11, 2025

Apr 09, 2025

Investors who lost money on Ventyx Biosciences, Inc.(VTYX) should contact Levi & Korsinsky about pending Class ActionVTYX - ACCESS Newswire

Apr 09, 2025

Apr 08, 2025

Is the Ventyx Biosciences Inc (NASDAQ:VTYX) stock an investment opportunity? - uspostnews.com

Apr 08, 2025

Apr 07, 2025

Ventyx Biosciences stock hits 52-week low at $0.89 amid market challenges - Investing.com Australia

Apr 07, 2025

Apr 07, 2025

Ventyx Biosciences stock hits 52-week low at $0.89 amid market challenges By Investing.com - Investing.com South Africa

Apr 07, 2025

Apr 07, 2025

Is Ventyx Biosciences Inc (NASDAQ: VTYX) Still Trending? - stocksregister.com

Apr 07, 2025

Apr 04, 2025

Ventyx Biosciences chief scientific officer John Nuss sells $2,019 in shares - Investing.com India

Apr 04, 2025

Apr 02, 2025

VTYX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Ventyx Biosciences, Inc. Investors Can Join the Class Action Lawsuit! - ACCESS Newswire

Apr 02, 2025

Apr 02, 2025

Shareholders that lost money on Ventyx Biosciences, Inc.(VTYX) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire

Apr 02, 2025

Apr 02, 2025

FINAL DEADLINE REMINDER: The Schall Law Firm Encourages Investors in Ventyx Biosciences, Inc. with Losses of $100,000 to Contact the Firm - ACCESS Newswire

Apr 02, 2025

Apr 02, 2025

Stock Traders Purchase Large Volume of Call Options on Ventyx Biosciences (NASDAQ:VTYX) - Defense World

Apr 02, 2025

Apr 01, 2025

Ventyx boosts advisory board with top scientists By Investing.com - Investing.com South Africa

Apr 01, 2025

Apr 01, 2025

Ventyx boosts advisory board with top scientists - Investing.com

Apr 01, 2025

Apr 01, 2025

Ventyx Biosciences Expands SAB with Renowned NLRP3 Experts - GlobeNewswire

Apr 01, 2025

Apr 01, 2025

7 World-Class NLRP3 Experts Join Ventyx as Phase 2 Trials Advance in Parkinson's Disease - Stock Titan

Apr 01, 2025

Mar 31, 2025

Insiders' US$1.26m Investments In Red Following Ventyx Biosciences' US$11m Dip In Market Value - simplywall.st

Mar 31, 2025

Mar 28, 2025

Ventyx Biosciences stock hits 52-week low at $1.21 amid market challenges - Investing.com

Mar 28, 2025

Mar 27, 2025

VTYX Stock Sees Decline of Approximately -9.63% in Last Five Days - knoxdaily.com

Mar 27, 2025

Mar 21, 2025

Ventyx Biosciences stock hits 52-week low at $1.28 amid market challenges - Investing.com Australia

Mar 21, 2025

Mar 15, 2025

Ventyx Biosciences Faces Supply Chain Risks Amidst U.S.-China Tensions and Regulatory Challenges - MSN

Mar 15, 2025

Mar 11, 2025

Ventyx Biosciences stock hits 52-week low at $1.37 amid market challenges - Investing.com Australia

Mar 11, 2025

Mar 10, 2025

Rhumbline Advisers Acquires 40,813 Shares of Ventyx Biosciences, Inc. (NASDAQ:VTYX) - Defense World

Mar 10, 2025

Mar 08, 2025

Ventyx Biosciences, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky Before April 30, 2024 to Discuss Your Rights – VTYX - ACCESS Newswire

Mar 08, 2025

Mar 04, 2025

Ventyx Biosciences Reports 2024 Financial Results and Progress - TipRanks

Mar 04, 2025

Mar 04, 2025

Levi & Korsinsky Notifies Shareholders of Ventyx Biosciences, Inc.(VTYX) of a Class Action Lawsuit and an Upcoming Deadline - ACCESS Newswire

Mar 04, 2025

Mar 03, 2025

Ventyx Biosciences stock hits 52-week low at $1.41 amid market challenges - Investing.com India

Mar 03, 2025

Mar 03, 2025

Ventyx Biosciences stock hits 52-week low at $1.41 amid market challenges By Investing.com - Investing.com South Africa

Mar 03, 2025

Mar 03, 2025

FINAL DEADLINE IMMINENT: The Schall Law Firm Encourages Investors in Ventyx Biosciences, Inc. with Losses of $100,000 to Contact the Firm - ACCESS Newswire

Mar 03, 2025

Mar 03, 2025

Class Action Filed Against Ventyx Biosciences, Inc. (VTYX)April 30, 2024 Deadline to JoinContact Levi & Korsinsky - ACCESS Newswire

Mar 03, 2025